[CAS NO. 899431-18-6]  A-438079 HCl

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [899431-18-6]

Catalog
SLK-S7705
Brand
Selleck
CAS
899431-18-6

DESCRIPTION [899431-18-6]

Overview

MDLMFCD09971142
Molecular Weight342.61
Molecular FormulaC13H10Cl3N5
SMILESClC1=C(Cl)C(C2=NN=NN2CC3=CC=CN=C3)=CC=C1.[H]Cl

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.9188 mL14.5939 mL29.1877 mL
5 mM0.5838 mL2.9188 mL5.8375 mL
10 mM0.2919 mL1.4594 mL2.9188 mL
50 mM0.0584 mL0.2919 mL0.5838 mL

Description

A-438079 HCl is a potent, and selective antagonist with of 6.9.

Targets

P2X7 [1]
(in 1321N1 cells)
6.9(pIC50)

In vitro

In 1321N1 cells stably expressing rat P2X receptors, A-438079 blocks BzATP-(10 μM) evoked changes in intracellular calcium concentrations with an IC50 of 321 nM. A-438079 is also selective for the P2X7 receptor, at concentrations up to 100 μM.

In vivo

Intraperitoneal injection of A-438079 (5 and 15 mg/kg) 60 min after triggering seizures reduces seizure severity and neuronal death within the hippocampus. A-438079 has superior neuroprotective effects compared with an equally dose of phenobarbital (25 mg/kg). A-438079 partially but significantly prevents the 6-OHDA-induced depletion of striatal DA stores. Pretreatment with A-438079 reduces nociceptive behaviour scores in the HC model. A-438079 (80 μmol/kg, i.v.) reduces noxious and innocuous evoked activity of different classes of spinal neurons in neuropathic rats. A-438079 (100 and 300 μmol/kg, i.p.) significantly raises withdrawal thresh-olds in both the SNL and CCI models.